Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Febuxostat × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 59 Cisplatin 40 Pemetrexed 36 Drug Therapy 35 osimertinib 23 anlotinib 19 Etoposide 19 Paclitaxel 18 Surgical Procedures, Operative 17 tislelizumab 16 pembrolizumab 15 toripalimab 14 Radiotherapy 14 130-nm albumin-bound paclitaxel 14 aflutinib 12 Docetaxel 11 Bevacizumab 11 sintilimab 10 Injections 10 durvalumab 9 Specimen Handling 9 Platinum 8 Magnetic Resonance Spectroscopy 8 Immunotherapy 8 cemiplimab 7 atezolizumab 7 Radiosurgery 7 Platinum Compounds 7 PM 01183 7 lorlatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07485452 2026-03-20

OSIBBBOOST

Maastricht University Medical Center

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡